A Study in Pediatric Patients With Cystic Fibrosis Lung Disease

Clinical trial NCT00130182 · COMPLETED

Trial details

NCT number: NCT00130182
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2005-08-01
Primary completion: 2006-09-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.